Press Releases

WOODCLIFF LAKE, N.J., Sept. 24, 2019 /PRNewswire/ -- Eisai today announced the presentation of new data and analyses via one oral proffered paper presentation, four poster discussions and seven poster presentations at the 2019 European Society for Medical Oncology (ESMO) Annual Meeting from September 27 – Octobe

WASHINGTON, Sept. 24, 2019 /PRNewswire/ -- Aflac, a committed corporate ally to families facing childhood cancer, and

SEATTLE, Sept. 24, 2019 /PRNewswire/ -- A new report by RealSelf, the leading online resource to research aesthetic procedures and connect with doctors

NEW YORK, Sept. 24, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, today announced that Robb Knie, Chief Executive Officer, wil

AUSTIN, Texas, Sept. 24, 2019 /PRNewswire/ -- Santé Ventures, a healthcare and life sciences investment firm specializing in early-stage companies developing innovative new medical

HARLEYSVILLE, Pa., Sept. 24, 2019 /PRNewswire/ -- Alliance Contract Pharma (ACP) announced today that the Company's new $2 million L

DOVER, Delaware, Sept. 24, 2019 /PRNewswire/ -- CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Fenestrated Pedicle Screw System used in the treatment of patients with advanced stage spinal tumors.

BOTHELL, Wash., Sept. 24, 2019 /PRNewswire/ -- BioLife Solutions

SAN DIEGO, Sept. 24, 2019 /PRNewswire/ -- Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients

SALT LAKE CITY, Sept. 24, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviat